Netty Bos-Veneman

Dr. Netty Bos-Veneman is a Youth Health Care Physician affiliated with the Faculty of Medical Sciences at the University of Groningen, Netherlands. Her work is primarily conducted through the University Medical Center Groningen (UMCG), where she focuses on public health issues related to children and adolescents.

Her research interests span several critical areas in pediatric public health and neurology, with particular emphasis on youth health care, vaccination pain management, and neurological disorders such as Tourette Syndrome and tic disorders. She has published extensively on the immunological and genetic aspects of Tourette Syndrome, exploring connections between gene expression, catecholamine pathways, and tic severity. Her more recent work has focused on vaccination pain perception among children, parents, and healthcare professionals, as well as interventions to reduce pain during childhood immunizations.

Analysis of her publication record shows a clear evolution from neurological research on tic disorders toward more applied public health research on vaccination practices. Her earlier work (2010-2012) heavily focused on the genetic and immunological underpinnings of Tourette Syndrome, while her more recent publications (2017-2022) demonstrate a shift toward practical clinical interventions in pediatric vaccination procedures.

Dr. Bos-Veneman has been actively involved in significant collaborative research efforts, including the European clinical guidelines for Tourette Syndrome and other tic disorders. Her work has garnered substantial attention in the scientific community, with several publications receiving notable citations, particularly the European clinical guidelines which has been cited over 185 times according to Scopus.

She maintains an active research profile with connections across multiple disciplines including neuroscience, immunology, genetics, and public health. Her fingerprint analysis shows strong expertise in Tic Disorders (100%), Tourette Syndrome (98%), Gene Expression (39%), and Attention Deficit Hyperactivity Disorder (29%), demonstrating her specialized knowledge in these areas.